Proteomic biomarkers play a crucial role in cancer because they offer several advantages over traditional diagnostic methods. They can: - Enable early detection of cancer, often before symptoms appear. - Provide insights into the molecular mechanisms underlying the disease. - Help in stratifying patients based on their risk of cancer progression or response to therapy. - Facilitate the development of targeted therapies by identifying specific molecular targets.
